期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus
1
作者 Fa-Shun Liu Song Wang +3 位作者 xian-shan guo Zhen-Xiong Ye Hong-Ya Zhang Zhen Li 《World Journal of Diabetes》 SCIE 2023年第6期632-655,共24页
Obesity and type-2 diabetes mellitus(T2DM)are metabolic disorders.Obesity increases the risk of T2DM,and as obesity is becoming increasingly common,more individuals suffer from T2DM,which poses a considerable burden o... Obesity and type-2 diabetes mellitus(T2DM)are metabolic disorders.Obesity increases the risk of T2DM,and as obesity is becoming increasingly common,more individuals suffer from T2DM,which poses a considerable burden on health systems.Traditionally,pharmaceutical therapy together with lifestyle changes is used to treat obesity and T2DM to decrease the incidence of comorbidities and allcause mortality and to increase life expectancy.Bariatric surgery is increasingly replacing other forms of treatment of morbid obesity,especially in patients with refractory obesity,owing to its many benefits including good long-term outcomes and almost no weight regain.The bariatric surgery options have markedly changed recently,and laparoscopic sleeve gastrectomy(LSG)is gradually gaining popularity.LSG has become an effective and safe treatment for type-2 diabetes and morbid obesity,with a high cost-benefit ratio.Here,we review the mechanism associated with LSG treatment of T2DM,and we discuss clinical studies and animal experiments with regard to gastrointestinal hormones,gut microbiota,bile acids,and adipokines to clarify current treatment modalities for patients with obesity and T2DM. 展开更多
关键词 OBESITY Type-2 diabetes mellitus Laparoscopic sleeve gastrectomy Gastrointestinal hormones ADIPOKINES Gut microbiota Bile acids
下载PDF
2型糖尿病合并不同水平高血压患者甲状腺激素水平变化及其相关性研究 被引量:13
2
作者 郭献山 耿秀琴 +1 位作者 赵建林 陈玉风 《中国现代医学杂志》 CAS 北大核心 2017年第18期119-123,共5页
目的观察2型糖尿病(T2DM)合并不同水平高血压患者甲状腺激素水平的变化,并探讨其相关因素。方法选取T2DM合并高血压患者392例,根据血压水平分为正常血压组135例、高血压1级组107例、高血压2级组89例及高血压3级组61例。测定各组甲状腺... 目的观察2型糖尿病(T2DM)合并不同水平高血压患者甲状腺激素水平的变化,并探讨其相关因素。方法选取T2DM合并高血压患者392例,根据血压水平分为正常血压组135例、高血压1级组107例、高血压2级组89例及高血压3级组61例。测定各组甲状腺激素水平,包括游离三碘甲状腺原氨酸(FT3)、游离甲状腺激素(FT4)及促甲状腺激素(TSH),并采用Pearson相关分析和多元逐步回归分析指标间的相关性。结果(1)随高血压水平升高,各组TSH水平升高[0.42(0.22~0.88)vs 0.80(0.33~1.01)vs 1.45(0.97~2.11)vs 2.75(2.10~4.20)m IU/L]、FT3水平降低[(5.31±0.54)vs(4.79±0.66)vs(4.47±0.52)vs(3.51±0.30)pmol/L](P<0.05),而各组间FT4水平比较,差异无统计学意义[(16.26±2.71)vs(16.04±2.75)vs(15.39±3.41)vs(16.30±2.70)pmol/L](P>0.05);(2)Pearson相关分析发现,FT3与高血压分级和年龄呈负相关(r=-0.408和-0.194,P=0.000和0.042);FT4与TG呈负相关,与HDL-C呈正相关(r=-0.227和0.189,P=0.028和0.046),与高血压分级无相关性(r=0.017,P=0.463);TSH与高血压分级、BMI、TG、TC、LDL-C及SUA呈正相关(r=0.357、0.196、0.277、0.123、0.214和0.342,P=0.005、0.041、0.025、0.046、0.020和0.001),与Hb A1c呈负相关(r=-0.222,P=0.034);(3)多元逐步回归分析发现,高血压分级和年龄为FT3的影响因素(均P=0.00);高血压分级和SUA为TSH的影响因素(均P=0.00);FT4未发现影响因素。结论随着血压水平的升高,TSH水平升高、FT3水平降低及FT4水平无变化;高血压分级是FT3和TSH的影响因素。 展开更多
关键词 2型糖尿病 高血压 甲状腺激素 相关性
下载PDF
Advances in traditional Chinese medicine as adjuvant therapy for diabetic foot 被引量:8
3
作者 Fa-Shun Liu Yue Li +3 位作者 xian-shan guo Rui-Chen Liu Hong-Ya Zhang Zhen Li 《World Journal of Diabetes》 SCIE 2022年第10期851-860,共10页
Diabetes mellitus(DM)is a complex disease that often causes multiple systemic complications that have become a major international public health problem.Diabetic foot(DF)is one of the severe and frequent chronic compl... Diabetes mellitus(DM)is a complex disease that often causes multiple systemic complications that have become a major international public health problem.Diabetic foot(DF)is one of the severe and frequent chronic complications of DM due to vascular lesions and neuropathy.DF ulcers(DFU)affect approximately 15%of people with DM and are the leading cause of death and disability.The prevalence and recurrence of DF are worrisome,and morbidity and mortality are also on the rise,which poses a substantial socioeconomic burden.Treating DF is difficult for clinicians and requires multidisciplinary cooperation,combining local and systemic therapy to reduce amputation and case-fatality rates.Traditional Chinese Medicine(TCM)has received extensive attention due to noticeable therapeutic effects and few adverse reactions.In recent years,research on DF treatment by TCM has been increasing,and further progress has been made.TCM includes oral medication,injectable preparations,and adjuvant therapy.This article reviews the relevant research on TCM-related adjuvant therapy for DF.We describe current progress in TCM in terms of external application,acupuncture,massage,acupoint injection,foot bath,fumigation,and moxibustion,as well as the mechanisms involved. 展开更多
关键词 Diabetes Mellitus Diabetic foot Foot ulcers Traditional Chinese medicine Wound healing
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部